NasdaqGM - Nasdaq Real Time Price USD
Sionna Therapeutics, Inc. (SION)
15.44
+0.96
+(6.63%)
As of 11:02:45 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Operating Expense
77,068
70,556
50,333
41,372
Operating Income
-77,068
-70,556
-50,333
-41,372
Net Non Operating Interest Income Expense
10,038
8,170
2,769
1,132
Other Income Expense
707
698
301
--
Pretax Income
-66,323
-61,688
-47,263
-40,240
Net Income Common Stockholders
-66,323
-61,688
-47,263
-40,240
Diluted NI Available to Com Stockholders
-66,323
-61,688
-47,263
-40,240
Basic EPS
-1.50
-1.45
-1.70
-2.32
Diluted EPS
-1.50
-1.45
-1.70
-2.32
Basic Average Shares
44,124.39
42,444.74
27,797.08
17,332.47
Diluted Average Shares
44,124.39
42,444.74
27,797.08
17,332.47
Total Operating Income as Reported
-77,068
-70,556
-50,333
-41,372
Total Expenses
77,068
70,556
50,333
41,372
Net Income from Continuing & Discontinued Operation
-66,323
-61,688
-47,263
-40,240
Normalized Income
-66,323
-61,688
-47,263
-40,240
Interest Income
10,038
8,170
2,769
1,132
Net Interest Income
10,038
8,170
2,769
1,132
EBIT
-77,068
-70,556
-50,333
-41,372
EBITDA
-76,407
-69,888
-49,750
-41,250
Reconciled Depreciation
661
668
583
122
Net Income from Continuing Operation Net Minority Interest
-66,323
-61,688
-47,263
-40,240
Normalized EBITDA
-76,407
-69,888
-49,750
-41,250
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 2/7/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AARD Aardvark Therapeutics, Inc.
11.90
+2.06%
MAZE Maze Therapeutics, Inc.
14.01
+2.56%
MTSR Metsera, Inc.
28.26
-3.71%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
359.000
+5.53%
ARTV Artiva Biotherapeutics, Inc.
1.9550
+0.26%
CAMP CAMP4 THERAPEUTICS CORPORATION
1.9350
-0.26%
TYRA Tyra Biosciences, Inc.
9.57
-0.83%
9688.HK Zai Lab Limited
27.100
+12.22%
RAPP Rapport Therapeutics, Inc.
13.44
+9.80%
COYA Coya Therapeutics, Inc.
5.70
+0.88%